Dioxonaphthoimidazoliums are Potent and Selective Rogue Stem Cell Clearing Agents with SOX2-Suppressing Properties

Area of Science:

• Stem cell biology
• Pharmacology
• Regenerative medicine

Background:

• Pluripotent stem cells hold promise for regenerative medicine but pose a risk of tumor formation.
• Eliminating residual undifferentiated stem cells is crucial for clinical applications.
• Small molecule approaches offer advantages over non-pharmacological methods for stem cell clearance.

Purpose of the Study:

• To investigate the structural requirements for stemotoxicity of dioxonapthoimidazolium compounds.
• To identify potent analogues of YM155 with selective stem cell-killing properties.
• To elucidate the molecular mechanisms underlying the stem cell-clearing effects.

Main Methods:

• Synthesis and evaluation of dioxonaphthoimidazolium analogues.
• Assessment of stem cell toxicity and selectivity.
• Analysis of molecular targets including survivin, SOX2, and NF-κB signaling pathways.

Main Results:

• Dioxonaphthoimidazolium YM155 selectively induces cell death in undifferentiated stem cells.
• Structural analysis identified critical quinone and imidazolium moieties for stemotoxicity.
• Potent analogues suppressed survivin and decreased SOX2, potentially promoting differentiation.
• Phosphorylation of NF-κB p50 subunit was suppressed, suggesting a role for NF-κB signaling.

Conclusions:

• Dioxonaphthoimidazolium compounds possess stem cell-clearing properties crucial for regenerative medicine.
• Structural features of YM155 are key to its stemotoxicity, with potential for therapeutic optimization.
• The mechanism involves suppression of survivin and SOX2, possibly mediated by NF-κB signaling, reducing teratoma risk.